1. "Survivorship Research"
Formats
  1. Journal Article (8900)
  2. Meeting Abstract (5192)
  3. Book Section (571)
  4. Review (357)
  5. Editorial (225)
  6. Research Letter (132)
  7. Conference Paper (104)
  8. Correspondence (91)
  9. Guidelines (85)
  10. Miscellaneous (76)
  11. Book Whole (30)
Groups
  1. Survivorship Research (15763)
  2. Department of Medicine (9202)
  3. Population Sciences Research Program (5670)
  4. Solid Tumor Oncology Division (5184)
  5. Surgery (5131)
  6. Epidemiology and Biostatistics (3598)

More Groups

People
  1. Clifford Hudis (905)
  2. Kenneth Offit (788)
  3. Michael Zelefsky (754)
  4. Sergio Giralt (684)
  5. Mark Robson (676)
  6. Joachim Yahalom (625)

More People

Years
  1. 2025 (231)
  2. 2024 (802)
  3. 2023 (892)
  4. 2022 (906)
  5. 2021 (922)
  6. 2020 (930)

More Years

Publications
  1. Journal of Clinical Oncology (1873)
  2. International Journal of Radiation Oncology, Biology, Physics (908)
  3. Blood (685)
  4. Annals of Surgical Oncology (599)
  5. Cancer Research (333)
  6. Cancer (331)

More Publications

Publishers
  1. Elsevier Inc. (2658)
  2. American Society of Clinical Oncology (2019)
  3. Springer (1542)
  4. Wiley Blackwell (806)
  5. Oxford University Press (787)
  6. American Society of Hematology (748)

More Publishers

Results (15763)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Impact of HHV-6 in recipients of ex vivo T-cell depleted hematopoietic cell transplant
    Meeting Abstract

    Lee, Y. J.; Su, Y.; Tamari, R.; Jakubowski, A. A.; Giralt, S. A.; Papanicolaou, G. A.
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • The impact of intraoperative opioid, ketamine and dexmedetomidine administration on oncologic outcomes following kidney cancer surgery
    Meeting Abstract

    Silagy, A.; Hannum, M.; Coleman, J.; Russo, P.; Tan, K. S.; Fischer, G.; McCormick, P.; Hakimi, A. A.; Mincer, J.
    BJU International (2020)

    Fulltext@MSK | Save
  • Baseline immune status predicts response to adoptive therapy with CMV cytotoxic T-Cells for refractory CMV
    Meeting Abstract

    Fabrizio, V.; Rodriguez-Sanchez, I.; Mauguen, A.; Dahi, P. B.; O'Reilly, R. J.; Prockop, S. E.
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Infectious complications in aggressive B cell non-Hodgkin lymphoma after CD-19 chimeric antigen receptor T cell therapy
    Meeting Abstract

    Wudhikarn, K.; Pennisi, M.; Garcia Recio, M.; Maloy, M. A.; Shah, G. L.; Scordo, M.; Dahi, P. B.; Sauter, C. S.; Batlevi, C. W.; Palomba, M. L.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Host T-cells contribute to immune reconstitution and improved outcome in recipients of CD34 selected T-cell depleted allografts (TCD HCT) with full hematopoietic cell but persistent mixed T-cell chimerism
    Meeting Abstract

    O'Reilly, R. J.; Koehne, G.; Heller, G.; Boulad, F.; Castro-Malaspina, H.; Giralt, S. A.; Jakubowski, A. A.; Kernan, N. A.; Papadopoulos, E. B.; Perales, M.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Burden and impact of toxicities on outcomes for aggressive B cell non-Hodgkin lymphoma patients after CD19-directed chimeric antigen receptor T cell: Real-world experience
    Meeting Abstract

    Wudhikarn, K.; Pennisi, M.; Garcia Recio, M.; Flynn, J.; Maloy, M. A.; Devlin, S. M.; Batlevi, C. W.; Shah, G. L.; Scordo, M.; Palomba, M. L.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Effect of melphalan exposure in patients with lymphoma undergoing autologous hematopoietic stem cell transplant (AHCT)
    Meeting Abstract

    Lin, A.; Dahi, P. B.; Flynn, J.; Uruburo, C.; Mcgeary, I.; Schofield, R.; Bhatt, V.; DeRespiris, L.; Figgins, B.; Griffin, M.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Feasibility of administering anti-CD45 iodine ((131)I) apamistamab [Iomab-B] for targeted conditioning in older patients with active, relapsed or refractory AML without lead-lined rooms: Ongoing phase III SIERRA trial experience at 6 study sites
    Meeting Abstract

    Nath, R.; Chu, B.; Chen, L.; Sadeghi, A.; Senglaub, T.; Kaiser, L.; Saganich, C.; Zgaljardic, M.; Rutar, F.; Harling, S.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Feasibility of and decreased inpatient hospital days for non-Hodgkin lymphoma (NHL) and Hodgkin lymphoma (HL) patients with outpatient BEAM using daily etoposide and cytarabine and autologous hematopoietic stem cell transplantation (AHCT)
    Meeting Abstract

    Cavalier, K.; Cazeau, N.; Bhatt, V.; McElrath, C.; LeStrange, N. J.; Lachaud-Richard, M.; Inumerables, F.; Andrejko, M.; Batalha, J.; Cohen, A.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Comparison of conditioning regimens for allogeneic hematopoietic cell transplantation in non-Hodgkin lymphoma
    Meeting Abstract

    Peterson, K. T.; Lin, A.; Ruiz, J. D.; Zheng, J.; Devlin, S. M.; Shah, G. L.; Scordo, M.; Sauter, C. S.; Perales, M.; Giralt, S. A.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save